Exploiting metabolic susceptibilities in glioblastoma via glycolytic inhibition and ketogenic therapy.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e13558
Abstract: e13558 Background: Glioblastoma (GBM) remains one of the most lethal primary brain tumors in children and adults. Despite enormous efforts to elucidate the genetic and epigenetic drivers of this disease, the prognosis for patients diagnosed… read more here.
Keywords: metabolic susceptibilities; glycolytic inhibition; cell; inhibition ... See more keywords